Jiali Chen

512 total citations
10 papers, 205 citations indexed

About

Jiali Chen is a scholar working on Hepatology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Jiali Chen has authored 10 papers receiving a total of 205 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hepatology, 5 papers in Surgery and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Jiali Chen's work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cancer Mechanisms and Therapy (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Jiali Chen is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cancer Mechanisms and Therapy (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Jiali Chen collaborates with scholars based in China and United States. Jiali Chen's co-authors include Zhen Liu, Weidong Han, Hongming Pan, Yong Fang, Ke Su, Tao Gu, Ke Xu, Yue Yuan, Kun He and Lu Guo and has published in prestigious journals such as Journal of Controlled Release, Colloids and Surfaces B Biointerfaces and Pharmacological Research.

In The Last Decade

Jiali Chen

10 papers receiving 205 citations

Peers

Jiali Chen
Jiali Chen
Citations per year, relative to Jiali Chen Jiali Chen (= 1×) peers Ningyuan Wen

Countries citing papers authored by Jiali Chen

Since Specialization
Citations

This map shows the geographic impact of Jiali Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiali Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiali Chen more than expected).

Fields of papers citing papers by Jiali Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiali Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiali Chen. The network helps show where Jiali Chen may publish in the future.

Co-authorship network of co-authors of Jiali Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Jiali Chen. A scholar is included among the top collaborators of Jiali Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiali Chen. Jiali Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Chen, Jiali, et al.. (2024). Prognostic value of circulating tumor cells combined with neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma. World Journal of Gastrointestinal Oncology. 16(2). 372–385. 5 indexed citations
2.
Wang, Kaili, Hao Chen, Jiani Zheng, et al.. (2024). Engineered liposomes targeting hepatic stellate cells overcome pathological barriers and reverse liver fibrosis. Journal of Controlled Release. 368. 219–232. 22 indexed citations
3.
Han, Li, Ke Su, Ke Xu, et al.. (2023). PD-1 Inhibitors Combined with Antiangiogenic Therapy with or Without Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Propensity Matching Analysis. Journal of Hepatocellular Carcinoma. Volume 10. 1257–1266. 12 indexed citations
4.
Su, Ke, Tao Gu, Ke Xu, et al.. (2023). Construction and validation of a nomogram for HBV-related hepatocellular carcinoma: A large, multicenter study. Annals of Hepatology. 28(4). 101109–101109. 30 indexed citations
5.
Wang, Kaili, Hao Chen, Si Qin, et al.. (2023). Co-delivery of pirfenidone and siRNA in ZIF-based nanoparticles for dual inhibition of hepatic stellate cell activation in liver fibrotic therapy. Colloids and Surfaces B Biointerfaces. 231. 113567–113567. 11 indexed citations
7.
Li, Han, Jiali Chen, Ke Su, et al.. (2022). External radiotherapy combined with sorafenib has better efficacy in unresectable hepatocellular carcinoma: a systematic review and meta-analysis. Clinical and Experimental Medicine. 23(5). 1537–1549. 30 indexed citations
8.
Yang, Ze, et al.. (2021). Pediatric asthma control during the COVID‐19 pandemic: A systematic review and meta‐analysis. Pediatric Pulmonology. 57(1). 20–25. 30 indexed citations
9.
Hu, Qinsheng, Long Cheng, Jia‐Zhuang Xu, et al.. (2020). The efficacy and safety of ipriflavone in postmenopausal women with osteopenia or osteoporosis: A systematic review and meta-analysis. Pharmacological Research. 159. 104860–104860. 16 indexed citations
10.
Liu, Zhen, et al.. (2018). The Efficacy and Safety of Apatinib Treatment for Patients with Unresectable or Relapsed Liver Cancer: a retrospective study. Journal of Cancer. 9(16). 2773–2777. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026